Area of research
Immunology · Virology
Research interest
Research interests include HIV Research and Treatment, T-cell and B-cell Immunology, Immune Cell Function and Interaction, and SARS-CoV-2 and COVID-19 Research.
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaques
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
Archaic humans have contributed to large-scale variation in modern human T cell receptor genes
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
AIRR community curation and standardised representation for immunoglobulin and T cell receptor germline sets
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
Progress in vaccine development for infectious diseases—a Keystone Symposia report
Vaccination induces HIV broadly neutralizing antibody precursors in humans
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
Evasion of neutralising antibodies by omicron sublineage BA.2.75
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies
Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis
A semi-supervised Bayesian mixture modelling approach for joint batch correction and classification
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles
Diversity in immunogenomics: the value and the challenge
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction